Michael Kolodziej M.D
Vice President and Chief Innovation Officer, ADVI Health
Michael Kolodziej M.D. is Vice President and Chief Innovation Officer, ADVI Health. Dr. Kolodziej attended college and medical school at Washington University in St. Louis where he was Phi Beta Kappa and Alpha Omega Alpha. He completed internal medicine and hematology-oncology training at the University of Pennsylvania in Philadelphia. After completing training, Dr. Kolodziej joined the faculty at the University of Oklahoma School of Medicine where he was an associate professor.
He joined New York Oncology in the winter of 1998 and was a partner in the practice until December 2012. He was an active member of the US Oncology Pharmacy and Therapeutics committee, on the executive committee from 2002-2011, and chairman from 2004-2011. He served as Medical Director for Oncology Services for US Oncology from 2007-2011. In this role, he helped direct the implementation of the USON clinical pathways initiative, the integration of the USON EMR into this program, and the development of the USON disease management and advanced care planning programs, now known as Innovent Oncology.
He joined Aetna in January 2013 as National Medical Director, Oncology Solutions. While at Aetna, he directed Aetna’s oncology delivery reform pilots and was the architect of the Aetna Oncology Medical Home program. He was also active in Aetna’s pharmacy policy, condition analysis, and genetics subcommittees.
Dr. Kolodziej joined Flatiron Health in July 2016 as National Medical Director, Managed Care Strategy where he applied the core tech and data capabilities of Flatiron to facilitate practice transformation and success in alternative payment models.
He joined ADVI in October 2017. He is a Fellow of the American College of Physicians.He has published and spoken extensively on payment reform, personalized medicine, and practice care delivery transformation in oncology.
Gordon has crafted innovative, practical, & actionable business, oncology and payer strategies for oncology practices, drug distribution companies, and software companies. From oncology medical home to revolutionary employee benefit design, Gordon has created solutions to lower costs and increase measurable quality.
Aligning the interests and interactions of the stakeholders in cancer care is complex. Gordon provides a unique perspective based on his experience with pharma, distribution, providers, patient advocacy, payers, self-funded employers, benefits design, provider technology, clinical pathways, and medical home.
Gordon is known for excellence in executive level communication and working cross functionally. His strengths include identifying and building partnerships and opportunities.
Anne Llewellyn MS, RN, RN-BC, BHSA, CCM, CRRN
Anne Llewellyn is a registered nurse with over forty years of experience in critical care, risk management, case management, patient advocacy, healthcare publications and training and development. Anne has been a leader in the area of case management and was the President of the Case Management Society of America 2003-4. She was awarded their Lifetime Achievement Award in 2015 for her service to the case management industry.
In 2008, when working for Dorland Health, Anne and her team established the Professional Patient Advocate Institute. She is a founding member of the Patient Advocate Certification Board. She is currently the treasurer and also the Chair of the Certification Exam Committee.
Anne’s experience as a Brain tumor survivor led her to write a Blog, Nurses Advocates. The Blog allows Anne to share her personal experience as a patient and to assist consumers, caregivers and all members of the healthcare team in improving the delivery of care.
Zachary Pruitt, PhD, MHA, CPH
Dr. Zachary Pruitt is an Assistant Professor in the University of South Florida’s College of Public Health. Dr. Pruitt teaches undergraduate and graduate courses, including Understanding U.S. Health Care, Health Services Management, Quality Measurement and Improvement, Strategic Planning & Healthcare Marketing, and the Advanced Seminar in Health Care Management.
Prior to academics, Dr. Pruitt directed Medicaid operations and regulatory affairs for a small Florida health plan, and managed policy and compliance projects for a large publicly-traded managed care organization. His research interests include the examination of healthcare costs, quality, and access among those insured by Medicaid, healthcare management applications, patient navigator programs, and the integration of medical and social care for vulnerable populations. Dr. Pruitt serves on the Board of Directors of the Western Florida Chapter of the American College of Healthcare Executives.
ELIOT JEKOWSKY, PH.D., MD, MBA
Eliot has more than 30 years of experience in healthcare, as a provider and a medical director for a large health insurance company. He studied protein synthesis in prokaryotes at M.I.T. leading to a Ph.D. in biochemistry, followed by a postdoctoral fellowship in clinical chemistry at New England Deaconess Hospital in Boston, Mass. He was the Assistant Director of Clinical Chemistry at Massachusetts General Hospital in Boston, Mass for two years before pursuing more clinically related interests by enrolling in the University of Miami Ph.D. to M.D. program, where he obtained an M.D. degree in two years. This was followed by an internship and residency in primary care internal medicine at Cambridge Hospital, an affiliate of Harvard Medical School. After completing his residency and becoming board certified in internal medicine, he began practicing emergency medicine, eventually obtaining board certification in that specialty as well. He worked full time as a staff ED physician as well as holding a position as Associate Director.
Dr. Jekowsky enrolled in an executive M.B.A. program while continuing to practice, receiving an M.B.A. in High Technology from Northeastern University. This led to an opportunity to join a health insurance company in Rhode Island as a physician reviewer and then to a position as a medical director at an insurer in Massachusetts. He recently retired from the position of Medical Director for Medical Policy and Medicare Advantage. As a result of his training and experience, Dr. Jekowsky has a broad view of the clinical needs for medical testing and treatments, the science behind the tests and procedures in genomic medicine, and knowledge of the business processes required for successfully bringing products to market.